NCT07713823

Brief Summary

Combining retrospective observational research with artificial intelligence data engineering. Collecting historical electronic medical record data, and through data governance and annotation by artificial medical experts, constructing a structured knowledge base.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
22mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

July 21, 2026

Status Verified

July 1, 2026

Enrollment Period

12 months

First QC Date

July 13, 2026

Last Update Submit

July 19, 2026

Conditions

Pancreatic CancerPancreatic Cancer MetastaticPancreatic Cancer Non-resectablePancreatic Cancer Resectable

Outcome Measures

Primary Outcomes (1)

  • 3,000 Cases of Pancreatic Cancer Diagnosis and Treatment

    May 2028

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Real pancreatic cancer diagnosis and treatment cases treated in the hospital

You may qualify if:

  • Real inpatient cases of pancreatic cancer diagnosis and treatment;
  • Possess complete electronic medical information (including but not limited to: outpatient medical records, inpatient medical records including admission records, progress notes, surgery/procedure records, nursing records, examination and test reports, doctor's orders, discharge/death records, etc.); -

You may not qualify if:

  • Cases that only underwent a brief transition in emergency/outpatient departments and did not form a closed loop of diagnosis and treatment;
  • Cases with incomplete diagnosis and treatment information and missing key indicators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Central Study Contacts

Long Jiang, MD

CONTACT

18017317460jiang.long@shgh.cn

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 13, 2026

First Posted

July 20, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

May 31, 2028

Last Updated

July 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share